GDMT
GDMT is a pharmaceutical drug with 8 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
3
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluating Adherence to Guideline-Directed Medical Therapy in Patients With Advanced Heart Failure
Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy
Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy
Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction
Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)
Clinical Trials (8)
Evaluating Adherence to Guideline-Directed Medical Therapy in Patients With Advanced Heart Failure
Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy
Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy
Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction
Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)
Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction
Randomized Evaluation and Verification of Ventricular Enhancement
Thoracic Epidural Anesthesia Reduces Mortality and Rehospitalization for Patients With Heart Failure With Reduced Ejection Fraction
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8